Q2 2021 · 13F-HR
ACT CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2021-08-16 · accession 0001636587-21-000026
$194,599
Reported value
117
Positions
2021-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 852312305 | STAA | STAAR SURGICAL CO | $35,319 | 18.1% | 231,600 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $17,277 | 8.88% | 208,600 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $15,408 | 7.92% | 455,300 | Common | SOLE |
| 185063104 | CLSDUSD | CLEARSIDE BIOMEDICAL INC | $11,993 | 6.16% | 2,462,500 | Common | SOLE |
| 35953D104 | FUBOGBP | FUBOTV INC | $8,606 | 4.42% | 268,000 | Common | SOLE |
| 04537Y109 | — | ASPIRA WOMENS HEALTH INC | $6,355 | 3.27% | 1,130,720 | Common | SOLE |
| 89620X506 | TREUR | TRILLIUM THERAPEUTICS INC | $4,511 | 2.32% | 465,000 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $3,845 | 1.98% | 45,000 | Common | SOLE |
| 44934S206 | ICADUSD | ICAD INC | $3,844 | 1.98% | 222,000 | Common | SOLE |
| 91332U101 | U | UNITY SOFTWARE INC | $3,306 | 1.70% | 30,100 | Common | SOLE |
| 91680M107 | UPST | UPSTART HLDGS INC | $3,098 | 1.59% | 24,800 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $2,941 | 1.51% | 25,900 | Common | SOLE |
| 88331L108 | SKIN | THE BEAUTY HEALTH COMPANY | $2,902 | 1.49% | 172,750 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $2,772 | 1.42% | 161,500 | Common | SOLE |
| 315616102 | FFIV | F5 NETWORKS INC | $2,707 | 1.39% | 14,500 | Common | SOLE |
| 45719W106 | — | INHIBIKASE THERAPEUTICS INC COM | $2,450 | 1.26% | 875,000 | Common | SOLE |
| N01045108 | — | AFFIMED N V | $2,445 | 1.26% | 287,600 | Common | SOLE |
| 64049K104 | — | NEOLEUKIN THERAPEUTICS INC | $2,207 | 1.13% | 239,000 | Common | SOLE |
| 670002401 | NVAX | NOVAVAX INC | $2,187 | 1.12% | 10,300 | Common | SOLE |
| M5425M103 | INMD | INMODE LTD COM | $2,140 | 1.10% | 22,600 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2,134 | 1.10% | 55,000 | Common | SOLE |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $2,106 | 1.08% | 162,500 | Common | SOLE |
| 67020Y100 | — | NUANCE COMMUNICATIONS INC | $2,042 | 1.05% | 37,500 | Common | SOLE |
| G637AM102 | — | MYOVANT SCIENCES LTD | $1,993 | 1.02% | 87,500 | Common | SOLE |
| 68235C107 | — | ONCOCYTE CORPORATION | $1,895 | 0.97% | 330,000 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP | $1,884 | 0.97% | 10,500 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $1,818 | 0.93% | 116,900 | Common | SOLE |
| 75615P103 | — | REATA PHARMACEUTICALS INC | $1,784 | 0.92% | 12,600 | Common | SOLE |
| 68236P107 | GTXIEUR | ONCTERNAL THERAPEUTICS INC | $1,710 | 0.88% | 360,000 | Common | SOLE |
| 38286R105 | — | GORES HOLDINGS VI INC | $1,605 | 0.82% | 99,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $1,453 | 0.75% | 69,200 | Common | SOLE |
| 28249U105 | CLDNEUR | EIGER BIOPHARMACEUTICALS INC | $1,351 | 0.69% | 158,500 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $1,298 | 0.67% | 19,075 | Common | SOLE |
| 86877M209 | — | SURFACE ONCOLOGY INC | $1,272 | 0.65% | 170,500 | Common | SOLE |
| 09075P105 | BTAIEUR | BIOXCEL THERAPEUTICS INC | $1,221 | 0.63% | 42,000 | Common | SOLE |
| 57055L107 | — | MARKER THERAPEUTICS INC | $1,172 | 0.60% | 420,000 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $1,058 | 0.54% | 4,500 | Common | SOLE |
| 58490H107 | MDNAF | MEDICENNA THERAPEUTICS CORP | $1,054 | 0.54% | 350,000 | Common | SOLE |
| 03615A108 | ANVS | ANNOVIS BIO INC COM | $1,027 | 0.53% | 12,000 | Common | SOLE |
| 483119103 | — | KALA PHARMACEUTICALS INC | $1,007 | 0.52% | 190,000 | Common | SOLE |
| 42328V603 | — | HELIUS MED TECHNOLOGIES INC | $1,002 | 0.51% | 59,186 | Common | SOLE |
| 757468103 | — | REDHILL BIOPHARMA LTD | $964 | 0.50% | 140,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $911 | 0.47% | 13,500 | Common | SOLE |
| 46428Q109 | SLV | ISHARES SILVER TR | $872 | 0.45% | 36,000 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $791 | 0.41% | 24,700 | Common | SOLE |
| 74838J101 | — | QUIDEL CORP | $782 | 0.40% | 6,100 | Common | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $780 | 0.40% | 37,500 | Common | SOLE |
| 345370860 | F | FORD MTR CO DEL | $773 | 0.40% | 52,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $770 | 0.40% | 128,500 | Common | SOLE |
| 91531W106 | TIGR | UP FINTECH HOLDING LIMITED | $739 | 0.38% | 25,500 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N V | $738 | 0.38% | 63,500 | Common | SOLE |
| M4130Y106 | ENLV | ENLIVEX THERAPEUTICS LTD | $735 | 0.38% | 82,500 | Common | SOLE |
| 67066G104 | NVDA | NVIDIA CORPORATION | $721 | 0.37% | 900 | Common | SOLE |
| 29667K306 | — | ESPORTS ENTMT GROUP INC | $706 | 0.36% | 65,000 | Common | SOLE |
| 023135106 | AMZN | AMAZON.COM INC | $689 | 0.35% | 200 | Common | SOLE |
| 19260Q107 | COIN | COINBASE GLOBAL INC | $684 | 0.35% | 2,700 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $682 | 0.35% | 102,500 | Common | SOLE |
| 231269200 | — | CURIS INC | $646 | 0.33% | 80,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $607 | 0.31% | 31,000 | Common | SOLE |
| 162828107 | — | CHECKPOINT THERAPEUTICS INC | $605 | 0.31% | 205,000 | Common | SOLE |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $565 | 0.29% | 45,000 | Common | SOLE |
| 88076W103 | TDC | TERADATA CORP | $550 | 0.28% | 11,000 | Common | SOLE |
| 69242L106 | OYST | OYSTER PT PHARMA INC | $542 | 0.28% | 31,500 | Common | SOLE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $541 | 0.28% | 16,071 | Common | SOLE |
| 084310101 | — | BERKELEY LTS INC | $538 | 0.28% | 12,000 | Common | SOLE |
| 15870P307 | CSBR | CHAMPIONS ONCOLOGY INC | $514 | 0.26% | 50,000 | Common | SOLE |
| 829399104 | — | SIO GENE THERAPIES INC | $506 | 0.26% | 185,000 | Common | SOLE |
| 03209T109 | — | AMPIO PHARMACEUTICALS INC | $487 | 0.25% | 291,500 | Common | SOLE |
| 48138M105 | JMIA | JUMIA TECHNOLOGIES AG | $440 | 0.23% | 14,500 | Common | SOLE |
| 05070N103 | — | AUDACY INC | $421 | 0.22% | 97,500 | Common | SOLE |
| 77311W101 | RKT | ROCKET COS INC | $420 | 0.22% | 21,700 | Common | SOLE |
| 51476H100 | — | LANDCADIA HOLDINGS III INC | $403 | 0.21% | 32,500 | Common | SOLE |
| 60800C109 | — | MOGO INC COM | $373 | 0.19% | 47,500 | Common | SOLE |
| 00827B106 | AFRM | AFFIRM HLDGS INC | $337 | 0.17% | 5,000 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $328 | 0.17% | 12,000 | Common | SOLE |
| 92840H202 | — | VISTAGEN THERAPEUTICS INC | $315 | 0.16% | 100,000 | Common | SOLE |
| 45665G303 | INFIQ | INFINITY PHARMACEUTICALS INC | $300 | 0.15% | 100,200 | Common | SOLE |
| 87184Q107 | — | SYROS PHARMACEUTICALS INC | $287 | 0.15% | 52,500 | Common | SOLE |
| 98459U103 | YALA | YALLA GROUP LTD | $270 | 0.14% | 13,500 | Common | SOLE |
| 23283X206 | CTSO | CYTOSORBENTS CORP | $265 | 0.14% | 35,000 | Common | SOLE |
| 15117F500 | — | CELLECTAR BIOSCIENCES INC | $259 | 0.13% | 217,500 | Common | SOLE |
| 09075F107 | — | BIONANO GENOMICS INC | $257 | 0.13% | 35,000 | Common | SOLE |
| 48669G105 | KZIAUSD | KAZIA THERAPEUTICS LIMITED | $247 | 0.13% | 25,000 | Common | SOLE |
| 29385B109 | EGLXF | ENTHUSIAST GAMING HOLDINGS INC | $238 | 0.12% | 40,000 | Common | SOLE |
| 52187K101 | — | LEAP THERAPEUTICS INC | $220 | 0.11% | 134,000 | Common | SOLE |
| 45783C101 | — | INSTIL BIO INC | $194 | 0.10% | 10,000 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $185 | 0.10% | 28,500 | Common | SOLE |
| M2R51X116 | CLGN | COLLPLANT BIOTECHNOLOGIES LT | $160 | 0.08% | 7,500 | Common | SOLE |
| 704551100 | BTU | PEABODY ENGR CORP | $159 | 0.08% | 20,000 | Common | SOLE |
| 49639K101 | KC | KINGSOFT CLOUD HLDGS LTD | $153 | 0.08% | 4,500 | Common | SOLE |
| 37186H100 | — | GENETRON HOLDINGS LIMITED | $152 | 0.08% | 7,500 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $145 | 0.07% | 14,000 | Common | SOLE |
| 03890D108 | VSAREUR | ARAVIVE INC | $141 | 0.07% | 23,500 | Common | SOLE |
| 92534K107 | VTNRUSD | VERTEX ENERGY INC | $139 | 0.07% | 10,500 | Common | SOLE |
| 078771300 | — | BELLEROPHON THERAPEUTICS INC | $121 | 0.06% | 25,000 | Common | SOLE |
| 868153107 | SDPIUSD | SUPERIOR DRILLING PRODS INC | $113 | 0.06% | 122,500 | Common | SOLE |
| 78472W104 | SQZB | SQZ BIOTECHNOLOGIES CO | $109 | 0.06% | 7,500 | Common | SOLE |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $90 | 0.05% | 6,500 | Common | SOLE |
| 03820J100 | — | APPLIED GENETIC TECHNOLOGIES | $79 | 0.04% | 20,000 | Common | SOLE |
| 98979V102 | ZVOI | ZOVIO INC | $78 | 0.04% | 30,000 | Common | SOLE |
| 09071M205 | — | BIOLINE RX LTD | $78 | 0.04% | 27,500 | Common | SOLE |
| 05337M104 | — | AVADEL PHARMACEUTICALS PLC | $71 | 0.04% | 10,500 | Common | SOLE |
| 189464100 | CLVSN | CLOVIS ONCOLOGY INC | $70 | 0.04% | 12,000 | Common | SOLE |
| 185899101 | CLF | CLEVELAND-CLIFFS INC NEW | $65 | 0.03% | 3,000 | Common | SOLE |
| 747798106 | HTT | QUDIAN INC | $61 | 0.03% | 25,000 | Common | SOLE |
| 053734604 | — | AVINGER INC | $44 | 0.02% | 35,000 | Common | SOLE |
| 74841Q100 | — | QUHUO LTD | $44 | 0.02% | 9,900 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $33 | 0.02% | 1,000 | Common | SOLE |
| 05455M100 | — | AVROBIO INC | $27 | 0.01% | 3,000 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS INC | $17 | 0.01% | 1,500 | Common | SOLE |
| 23127P104 | AVRW | CURE PHARMACEUTICAL HLDG CORP | $16 | 0.01% | 30,000 | Common | SOLE |
| 372427401 | GNCAQ | GENOCEA BIOSCIENCES INC | $12 | 0.01% | 5,000 | Common | SOLE |
| 29604W108 | — | ERYTECH PHARMA | $10 | 0.01% | 2,000 | Common | SOLE |
| 009066101 | ABNB | AIRBNB INC | $8 | 0.00% | 50 | Common | SOLE |
| G5279F102 | — | EZGO TECHNOLOGIES LTD | $5 | 0.00% | 1,000 | Common | SOLE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $2 | 0.00% | 90 | Common | SOLE |
| 12468P104 | AI | C3 AI INC | $1 | 0.00% | 80 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.